InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Romano Kathryn, Chief Accounting Officer. Director active across 1 company, notably Krystal Biotech, Inc.. Aggregated, 10 disclosures have been recorded. Activity tracked since 26 February 2022. The latest transaction was filed on 27 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Romano Kathryn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
7,500 股0Common StockSEC:0001801385-26-000002:0
12,500 股@ US$63.5549.3% 占其流量Common StockSEC:0001711279-26-000011:0
2,268 股@ US$176.3955.1% 占其流量Common StockSEC:0001801385-25-000002:0
523 股@ US$63.554.4% 占其流量Common StockSEC:0001801385-24-000009:0
648 股@ US$63.555.5% 占其流量Common StockSEC:0001801385-24-000011:0
5,000 股@ US$52.2635.0% 占其流量Common StockSEC:0001801385-24-000007:0
2,500 股@ US$52.2612.4% 占其流量Common StockSEC:0001801385-24-000002:0
12,500 股@ US$52.2662.7% 占其流量Common StockSEC:0001801385-23-000004:0
2,144 股@ US$78.4616.4% 占其流量Common StockSEC:0001801385-23-000002:0
1,472 股@ US$62.500.0011% mcap100.0% 占其流量Common StockSEC:0001801385-22-000005:0
10 条申报中的 10 条
About Romano Kathryn
Kathryn Romano is the Chief Accounting Officer at Krystal Biotech, Inc. She is responsible for overseeing the accounting and financial operations of the company. Romano plays a key role in managing financial resources and in developing financial reports that comply with standards.
